Merck
Medicine & Biotech · covered by 9 outlets this week · tracked since 2026-10-27
Press: 5 mainstream 4 specialist outlet-days
Coverage
review
Merck drug extends survival in endometrial cancer trial, wins U.S. priority review
The Hindu Health · 11h ago
study
STAT+: Merck ADC drug cut risk of death by one-third in advanced endometrial cancer
STAT News · 1d ago
study
Merck's melanoma vaccine trial shows reduced recurrence or death from skin cancer
NPR Health · 1d ago
STAT+: Moderna CEO on what’s next after success in cancer vaccine
STAT Biotech · 1d ago
Milestone cancer vaccine success leaves hard questions unanswered
Science Magazine News · 1d ago
esnot translated yet
Las vacunas contra el cáncer: sí, pero aún no
El País Salud y Bienestar · 2d ago
denot translated yet
mRNA-Impfstoff: Impfstoff senkt laut Studie Rückfall bei Hautkrebs um 42 Prozent
Zeit Gesundheit · 4d ago
study
Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna Report
NYT Well · 4d ago